Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.

Sharpe M, Walker J, Holm Hansen C, Martin P, Symeonides S, Gourley C, Wall L, Weller D, Murray G; SMaRT (Symptom Management Research Trials) Oncology-2 Team.

Lancet. 2014 Sep 20;384(9948):1099-108. doi: 10.1016/S0140-6736(14)61231-9. Epub 2014 Aug 27.

PMID:
25175478
2.

The symptom cluster-based approach to individualize patient-centered treatment for major depression.

Lin SY, Stevens MB.

J Am Board Fam Med. 2014 Jan-Feb;27(1):151-9. doi: 10.3122/jabfm.2014.01.130145.

3.

Socioeconomic deprivation independently predicts symptomatic painful diabetic neuropathy in type 1 diabetes.

Anderson SG, Malipatil NS, Roberts H, Dunn G, Heald AH.

Prim Care Diabetes. 2014 Apr;8(1):65-9. doi: 10.1016/j.pcd.2013.08.004. Epub 2013 Nov 8.

PMID:
24211151
4.

Effectiveness and cost-effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo-controlled multi-Centre trial: TCC:PAINDIP.

de Heer EW, Dekker J, van Eck van der Sluijs JF, Beekman AT, van Marwijk HW, Holwerda TJ, Bet PM, Roth J, Hakkaart-Van Roijen L, Ringoir L, Kat F, van der Feltz-Cornelis CM.

BMC Psychiatry. 2013 May 24;13:147. doi: 10.1186/1471-244X-13-147.

5.

Using the analytic hierarchy process to elicit patient preferences: prioritizing multiple outcome measures of antidepressant drug treatment.

Hummel MJ, Volz F, van Manen JG, Danner M, Dintsios CM, Ijzerman MJ, Gerber A.

Patient. 2012;5(4):225-37. doi: 10.2165/11635240-000000000-00000.

PMID:
23098363
6.

Duloxetine versus other anti-depressive agents for depression.

Cipriani A, Koesters M, Furukawa TA, Nosè M, Purgato M, Omori IM, Trespidi C, Barbui C.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD006533. doi: 10.1002/14651858.CD006533.pub2. Review.

7.

How family physicians address diagnosis and management of depression in palliative care patients.

Warmenhoven F, van Rijswijk E, van Hoogstraten E, van Spaendonck K, Lucassen P, Prins J, Vissers K, van Weel C.

Ann Fam Med. 2012 Jul-Aug;10(4):330-6. doi: 10.1370/afm.1373.

8.

Diagnosis and treatment of depression in adults with comorbid medical conditions: a 52-year-old man with depression.

Whooley MA.

JAMA. 2012 May 2;307(17):1848-57. doi: 10.1001/jama.2012.3466.

PMID:
22550199
9.

Healthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom.

Shi N, Cao Z, Durden E, Schacht A, Torres A, Happich M.

J Med Econ. 2012;15(4):672-80. doi: 10.3111/13696998.2012.672941. Epub 2012 Mar 20.

PMID:
22390770
10.

Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial.

Sattel H, Lahmann C, Gündel H, Guthrie E, Kruse J, Noll-Hussong M, Ohmann C, Ronel J, Sack M, Sauer N, Schneider G, Henningsen P.

Br J Psychiatry. 2012 Jan;200(1):60-7. doi: 10.1192/bjp.bp.111.093526. Epub 2011 Nov 10.

11.

Psychological factors affecting response to antidepressant drugs in fibromyalgia.

Díaz-Marsá M, Palomares N, Morón MD, Tajima K, Fuentes ME, López-Ibor JJ, Carrasco JL.

Psychosomatics. 2011 May-Jun;52(3):237-44. doi: 10.1016/j.psym.2010.12.014.

PMID:
21565595
12.

Antidepressant treatment and cultural differences--a survey of the attitudes of physicians and patients in Sweden and Turkey.

Wade AG, Johnson PC, McConnachie A.

BMC Fam Pract. 2010 Nov 26;11:93. doi: 10.1186/1471-2296-11-93.

13.

Efficacy of 2 interventions for panic disorder in patients presenting to the ED with chest pain.

Pelland MÈ, Marchand A, Lessard MJ, Belleville G, Chauny JM, Vadeboncoeur A, Poitras J, Foldes-Busque G, Bacon SL, Lavoie KL.

Am J Emerg Med. 2011 Nov;29(9):1051-61. doi: 10.1016/j.ajem.2010.06.027. Epub 2010 Sep 25.

PMID:
20870368
14.

Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial.

Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, Albanese G, Kronish I, Hegel M, Burg MM.

Arch Intern Med. 2010 Apr 12;170(7):600-8. doi: 10.1001/archinternmed.2010.29.

15.

Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran.

Geisser ME, Clauw DJ, Strand V, Gendreau RM, Palmer R, Williams DA.

Pain. 2010 May;149(2):373-8. doi: 10.1016/j.pain.2010.02.043. Epub 2010 Mar 23.

PMID:
20332060
16.

Presence and predictors of pain in depression: results from the FINDER study.

Demyttenaere K, Reed C, Quail D, Bauer M, Dantchev N, Montejo AL, Monz B, Perahia D, Tylee A, Grassi L.

J Affect Disord. 2010 Sep;125(1-3):53-60. doi: 10.1016/j.jad.2010.02.106. Epub 2010 Feb 25.

PMID:
20188422
17.

Major depression: the importance of clinical characteristics and treatment response to prognosis.

Katon W, Unützer J, Russo J.

Depress Anxiety. 2010;27(1):19-26. doi: 10.1002/da.20613.

PMID:
19798766
18.

Appropriateness of antidepressant prescribing: an observational study in a Scottish primary-care setting.

Cameron IM, Lawton K, Reid IC.

Br J Gen Pract. 2009 Sep;59(566):644-9. doi: 10.3399/bjgp09X454061.

19.

[Diagnosis and therapy of depression in family practice].

Torzsa P, Szeifert L, Dunai K, Kalabay L, Novák M.

Orv Hetil. 2009 Sep 6;150(36):1684-93. doi: 10.1556/OH.2009.28675. Review. Hungarian.

PMID:
19709983
20.

Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial.

Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, Tu W.

JAMA. 2009 May 27;301(20):2099-110. doi: 10.1001/jama.2009.723.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk